Disseminated Mycobacterium celatum disease with prolonged pulmonary involvement | Zendy

Cecilie Blenstrup Patsche | Zendy; Erik Svensson | Zendy; Christian Wejse | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Disseminated Mycobacterium celatum disease with prolonged pulmonary involvement

Author(s) -

Cecilie Blenstrup Patsche,

Erik Svensson,

Christian Wejse

Publication year - 2014

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2014.02.020

Subject(s) - ethambutol , medicine , pyrazinamide , azithromycin , clarithromycin , isoniazid , regimen , disease , ciprofloxacin , mycobacterium tuberculosis , antimycobacterial , tuberculosis , antibiotics , immunology , pathology , microbiology and biotechnology , helicobacter pylori , biology

Mycobacterium celatum is a rare cause of human infection, causing disseminated disease in immunosuppressed individuals. Infections localized to the lungs and the lymph nodes have also been reported in immunocompetent individuals. The existing literature on the subject is limited as are experiences with treatment regimens and durations. In the case presented herein, two different treatment regimens were applied to an immunocompromised HIV-negative patient with primary skin involvement and extensive pulmonary involvement due to suspected relapse on isoniazid, ethambutol, and clarithromycin treatment. The treatment regimen was changed to azithromycin, ciprofloxacin, and pyrazinamide and the treatment duration was prolonged to a total of 24 months, with good effect.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research